Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Nicorette Cooldrops
Active Ingredient: Nicotine polacrilex 10.5mg equivalent to Nicotine 2.1mg
Dosage Form: Lozenge
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
Product: Nicorette Cooldrops
Active Ingredient: Nicotine polacrilex 21mg equivalent to Nicotine 4.2mg
Dosage Form: Lozenge
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
Dated this 29th day of November 2012.
DR MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health 6 July 2001).